Mingfang Lu

1.2k total citations
31 papers, 863 citations indexed

About

Mingfang Lu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mingfang Lu has authored 31 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Mingfang Lu's work include Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers) and Immune Cell Function and Interaction (7 papers). Mingfang Lu is often cited by papers focused on Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers) and Immune Cell Function and Interaction (7 papers). Mingfang Lu collaborates with scholars based in United States, China and Hong Kong. Mingfang Lu's co-authors include Robert S. Munford, Alan W. Varley, Yiwei Chu, Akira Takashima, Brian Janelsins, Sandip K. Datta, Jerrold Weiss, Mei Zhang, Joel A. Morales‐Rosado and Shoichiro Ohta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Mingfang Lu

29 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingfang Lu United States 18 455 301 115 111 65 31 863
Calum T. Robb United Kingdom 13 510 1.1× 304 1.0× 79 0.7× 108 1.0× 66 1.0× 22 970
Paula Giselle Czaikoski Brazil 10 562 1.2× 256 0.9× 167 1.5× 62 0.6× 77 1.2× 12 936
Kristine Vasquez United States 12 332 0.7× 209 0.7× 103 0.9× 135 1.2× 43 0.7× 17 937
Lise Lefèvre France 14 313 0.7× 303 1.0× 105 0.9× 62 0.6× 48 0.7× 18 729
Chantal S. Colmont United Kingdom 15 461 1.0× 469 1.6× 172 1.5× 92 0.8× 98 1.5× 19 1.2k
Sarah Ingersoll United States 15 287 0.6× 351 1.2× 112 1.0× 65 0.6× 127 2.0× 30 968
Shauna Dauphinee Canada 11 374 0.8× 353 1.2× 83 0.7× 60 0.5× 66 1.0× 18 813
Zhenwei Xia China 18 356 0.8× 515 1.7× 63 0.5× 183 1.6× 57 0.9× 46 941
Brittelle Bowers United States 9 358 0.8× 420 1.4× 99 0.9× 134 1.2× 129 2.0× 11 988
Silvia Galván-Peña United States 9 342 0.8× 431 1.4× 103 0.9× 82 0.7× 79 1.2× 10 835

Countries citing papers authored by Mingfang Lu

Since Specialization
Citations

This map shows the geographic impact of Mingfang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Lu more than expected).

Fields of papers citing papers by Mingfang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Lu. The network helps show where Mingfang Lu may publish in the future.

Co-authorship network of co-authors of Mingfang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Lu. A scholar is included among the top collaborators of Mingfang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Lu. Mingfang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, Lu, Jiayi Chen, Wei Jiang, et al.. (2025). Acyloxyacyl Hydrolase Prevents Colitis and Colitis‐Associated Colorectal Cancer by Inactivating Stimulatory LPS in the Intestine. The FASEB Journal. 39(8). e70566–e70566.
3.
Yang, Qian, Zihui Tang, Han Han, et al.. (2024). Alveolar epithelial cells shape lipopolysaccharide‐induced inflammatory responses and reprogramming of alveolar macrophages. European Journal of Immunology. 55(1). e2350378–e2350378.
4.
Wu, Chao, Tiancong Shi, Qian Cai, et al.. (2023). FAP expression in adipose tissue macrophages promotes obesity and metabolic inflammation. Proceedings of the National Academy of Sciences. 120(51). e2303075120–e2303075120. 20 indexed citations
5.
Lü, Jun, Huiping Qiang, Mingfang Lu, et al.. (2023). Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming. Advanced Therapeutics. 6(11). 5 indexed citations
6.
Wang, Zhiyan, Lu Gan, Changshun Li, et al.. (2023). Acyloxyacyl hydrolase promotes pulmonary defense by preventing alveolar macrophage tolerance. PLoS Pathogens. 19(7). e1011556–e1011556. 7 indexed citations
7.
Cheng, Xiaofang, Alan W. Varley, Guojun Qian, et al.. (2021). A host lipase prevents lipopolysaccharide-induced foam cell formation. iScience. 24(9). 103004–103004. 7 indexed citations
8.
Wang, Pingyuan, Xiaofang Cheng, Margery Smelkinson, et al.. (2021). Extracellular Acidity Reprograms Macrophage Metabolism and Innate Responsiveness. The Journal of Immunology. 206(12). 3021–3031. 6 indexed citations
9.
Munford, Robert S., Jerrold Weiss, & Mingfang Lu. (2020). Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery. Journal of Biological Chemistry. 295(51). 17842–17851. 20 indexed citations
10.
Lu, Meng, Lingling Xie, Lixia Liu, et al.. (2019). Temporal modulation of host aerobic glycolysis determines the outcome of Mycobacterium marinum infection. Fish & Shellfish Immunology. 96. 78–85. 8 indexed citations
11.
Zhang, Hongxia, Yuanyuan Li, Mingfang Lu, et al.. (2018). Difference in proinflammatory cytokines produced by monocytes between patients with major depressive disorder and healthy controls. Journal of Affective Disorders. 234. 305–310. 28 indexed citations
12.
Qian, Jiawen, Feifei Luo, Jiao Yang, et al.. (2018). TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia. Cancer Immunology Research. 6(10). 1220–1233. 83 indexed citations
13.
Han, Han, Zihui Tang, Qian Yang, et al.. (2017). Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury. PLoS Pathogens. 13(6). e1006436–e1006436. 45 indexed citations
14.
Lu, Mingfang, Alan W. Varley, & Robert S. Munford. (2013). Persistently Active Microbial Molecules Prolong Innate Immune Tolerance In Vivo. PLoS Pathogens. 9(5). e1003339–e1003339. 28 indexed citations
15.
Morales‐Rosado, Joel A., et al.. (2013). Toll-like Receptor Agonists Promote Prolonged Triglyceride Storage in Macrophages. Journal of Biological Chemistry. 289(5). 3001–3012. 92 indexed citations
16.
Janelsins, Brian, Mingfang Lu, & Sandip K. Datta. (2013). Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity. Proceedings of the National Academy of Sciences. 111(1). 373–378. 42 indexed citations
17.
Munford, Robert S., Mingfang Lu, & Alan W. Varley. (2009). Chapter 2 Kill the Bacteria…and Also Their Messengers?. Advances in immunology. 103. 29–48. 25 indexed citations
18.
Lu, Mingfang, et al.. (2008). Host Inactivation of Bacterial Lipopolysaccharide Prevents Prolonged Tolerance Following Gram-Negative Bacterial Infection. Cell Host & Microbe. 4(3). 293–302. 67 indexed citations
19.
Lu, Mingfang, Mei Zhang, Akira Takashima, et al.. (2005). Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nature Immunology. 6(10). 989–994. 55 indexed citations
20.
Lu, Mingfang, Mei Zhang, Richard L. Kitchens, et al.. (2003). Stimulus-dependent Deacylation of Bacterial Lipopolysaccharide by Dendritic Cells. The Journal of Experimental Medicine. 197(12). 1745–1754. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026